Page 140 - Williams Hematology ( PDFDrive )

114 Part III: Epochal Hematology Chapter 7: Hematology of the Fetus and Newborn 115

163. Harris MC, Levitt J, Douglas SD, et al: Effect of fibronectin on adherence of neutrophils 199. Bryson YJ, Winter HS, Gard SE, et al: Deficiency of immune interferon production by
from newborn infants. J Clin Microbiol 21:243, 1985. leukocytes of normal newborns. Cell Immunol 55:191, 1987.
164. Hill HR, Shigeoka AO, Gonzales LA, Christensen RD: Intravenous immune globulin 200. Frenkel L, Bryson YJ: Ontogeny of phytohemagglutinin-induced gamma interferon
use in newborns. J Allergy Clin Immunol 84:617, 1989. by leukocytes of healthy infants and children: Evidence for decreased production in
165. Christensen RD, Brown MS, Hall DC, et al: Effect on neutrophil kinetics and serum infants younger than 2 months of age. J Pediatr 111:97, 1987.
opsonic capacity of intravenous administration of immune globulin to neonates with 201. Perussia B, Dayton ET, Lazarus R, et al: Immune interferon induces the receptor for
clinical signs of early-onset sepsis. J Pediatr 118:606, 1991. monomeric IgG on human monocytic and myeloid cells. J Exp Med 158:1092, 1983.
166. Fujiwara T, Taniuchi S, Hattori K, et al: Effect of immunoglobulin therapy on phagocy- 202. Cairo MS: Review of G-CSF and GM-CSF effects on neonatal neutrophil kinetics. Am J
tosis by polymorphonuclear leucocytes in whole blood of neonates. Clin Exp Immunol Pediatr Hematol Oncol 11:238, 1989.
107:435, 1997. 203. Cairo MS, VandeVen C, Toy C, et al: GM-CSF primes and modulates neonatal PMN
167. Weisman LE, Stoll BJ, Kueser TJ, et al: Intravenous immune globulin therapy for ear- motility: Up-regulation of C3bi (Mol) expression with alteration in PMN adherence
ly-onset sepsis in premature neonates. J Pediatr 121:434, 1992. and aggregation. Am J Pediatr Hematol Oncol 13:249, 1991.
167. 8chreiber JR, Berger M: Intravenous immune globulin therapy for sepsis in premature 204. Sautois B, Fillet G, Beguin Y: Comparative cytokine production by in vitro stimulated
neonates. J Pediatr 121:401, 1992. mononucleated cells from cord blood and adult blood. Exp Hematol 25:103, 1997.
169. Baker CJ, Melish ME, Hall RT, et al: Intravenous immune globulin for the prevention of 205. Fogel BJ, Arais D, Kung F: Platelet counts in healthy premature infants. J Pediatr 73:108,
nosocomial infection in low-birth-weight infants. N Engl J Med 327:213, 1992. 1968.
170. Suri M, Harrison L, Van de Ven C, et al: Immunotherapy in the prophylaxis of neonatal 206. Sell EJ, Corrigan JJ: Platelet counts, fibrinogen concentrations and factor V and factor
sepsis. Curr Opin Pediatr 15:155, 2003. VIII levels in healthy infants according to gestational age. J Pediatr 82:1028, 1973.
171. Fischer GW, Weisman LE, Hemming VG: Directed immune globulin for the preven- 207. Mehta P, Vasa R, Neumann L, Karpatkin M: Thrombocytopenia in the high-risk infant.
tion or treatment of neonatal group B streptococcal infections: A review. Clin Immunol J Pediatr 97:791, 1980.
Immunopathol 62:S92, 1992. 208. Meberg A, Halvorsen S, Orstavik I: Transitory thrombocytopenia in small-for-dates
172. Miller ME: Chemotactic function in the neonate. Humoral and cellular aspects. Pediatr infants, possibly related to maternal smoking. Lancet 2:303, 1977.
Res 5:487, 1971. 209. Thuring W, Tonz O: Neonatale thrombozytenwerte be: Kindern mit Down-Syndrom
173. Klei RB, Fischer TJ, Gard SE, et al: Decreased mononuclear and polymorphonuclear und anderen autosomalen trisomien. Helv Paediatr Acta 34:545, 1979.
chemotaxis in human newborns, infants, and young children. Pediatrics 60:467, 1977. 210. Cairo, MS: The regulation of hematopoietic growth factor production from cord mono-
174. Tono-oka T, Nakayama M, Uehara H, et al: Characteristics of impaired chemotactic nuclear cells and its effect on newborn rat hematopoiesis. J Hematother 2:217, 1993.
function in cord blood leukocytes. Pediatr Res 13:148, 1979. 211. Suen Y, Chang M, Lee SM, et al: Regulation of interleukin-11 protein and mRNA
175. Hill HR, Augustine NH, Newton JA, et al: Correction of a developmental defect in expression in neonatal and adult fibroblasts and endothelial cells. Blood 84:4125, 1994.
neutrophil activation and movement. Am J Pathol 128:307, 1987. 212. Murray NA, Watts TL, Roberts IAG: Thrombopoietin in the fetus and neonate. Early
176. Bruce MC, Baley JE, Medvik KA, et al: Impaired surface membrane expression of C3bi Hum Dev 59:1, 2000.
but not C3b receptors on neonatal neutrophils. Pediatr Res 21:306, 1987. 213. Feusner JH: Normal and abnormal bleeding times in neonates and young children uti-
177. Anderson DC, Freeman KLB, Heerdt B, et al: Abnormal stimulated adherence of neo- lizing a fully standardized template technic. Am J Clin Pathol 74:73, 1980.
natal granulocytes: Impaired induction of surface MAC-1 by chemotactic factors or 214. Rennie JM, Gibson T, Cooke RWI: Micromethod for bleeding time in the newborn.
secretagogues. Blood 70:740, 1987. Arch Dis Child 60:51, 1985.
178. Carr R, Davies JM: Abnormal PcRIII expression by neutrophils from very preterm neo- 215. Andrew M, Paes B, Bowker J, Vegh P: Evaluation of an automated bleeding time device
nates. Blood 76:607, 1990. in the newborn. Am J Hematol 35:275, 1990.
189. Anderson DC, Rothlein R, Marlin SD, et al: Impaired transendothelial migration by 216. Weinstein MJ, Blanchard R, Moake JL, et al: Fetal and neonatal von Willebrand factor
neonatal neutrophils: Abnormalities of Mac-1(CD11b/CD18)-dependent adherence (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombo-
reactions. Blood 76:2613, 1990. cytopenic purpura. Br J Haematol 72:68, 1989.
180. Masuda K, Kinoshita Y, Kobayashi Y: Heterogeneity of Fc expression in chemotaxis and 217. Andrew M, Vegh P, Johnston M, et al: Maturation of the hemostatic system during
adherence of neonatal neutrophils. Pediatr Res 25:6, 1989. childhood. Blood 80:1998, 1992.
181. Tosi MF, Berger M: Functional differences between the 40 kDa and 50 kDa IgG Fc 218. Andrew M, Castle V, Saigal S, et al: Clinical impact of neonatal thrombocytopenia.
receptors on human neutrophils revealed by elastase treatment and antireceptor anti- J Pediatr 110:457, 1987.
bodies. J Immunol 141:2097, 1988. 219. Israels SJ, Rand ML, Michelson AD: Neonatal platelet function [review]. Semin Thromb
182. Koenig JM, Yoder MC: Neonatal neutrophils: The good, the bad and the ugly. Clin Hemost 29:363, 2003.
Perinatol 31:39-51, 2004. 220. Corazza MS, Davis RF, Merritt TA, et al: Prolonged bleeding time in preterm infants
183. Kim SK, Keeney SE, Alpard SK: Comparison of L-selectin and CD11b on neutrophils of receiving indomethacin for patent ductus arteriosus. J Pediatr 105:292, 1984.
adults and neonates during the first month of life. Pediatr Res 53:132-136, 2003. 221. Israels SJ, Cheang T, McMillan-Ward EM, et al: Evaluation of primary hemostasis in
184. Mills EL, Thompson T, Bjorksten B, et al: The chemiluminescence response and bac- neonates with a new in vitro platelet function analyzer. J Pediatr 138:116, 2001.
tericidal activity of polymorphonuclear neutrophils from newborns and their mothers. 222. Knofler R, Weissbach G, Kuhlisch E: Platelet function tests in childhood. Measuring
Pediatrics 63:429, 1979. aggregation and release reaction in whole blood. Semin Thromb Hemost 24:513, 1998.
185. Park BH, Holmes B, Good RA: Metabolic activities in leukocytes of newborn infants. J 223. Saxonhouse MA, Sola MC: Platelet function in term and preterm neonates. Clin Perina-
Pediatr 76:237, 1970. tol 31:15, 2004.
186. Xanthou M, Valassi-Adam E, Kintronidou E, et al: Phagocytosis and killing ability of 224. Stuart MJ: Platelet function in the neonate. Am J Pediatr Hematol Oncol 1:227, 1979.
Candida albicans by blood leucocytes of healthy term and preterm babies. Arch Dis 225. Israels SJ, Daniels M, McMillan EM: Deficient collagen-induced activation in the new-
Child 50:72, 1975. born platelet. Pediatr Res 27:337, 1990.
187. Shigeoka AO, Charette RP, Wyman ML, et al: Defective oxidative metabolic responses 226. Rajasekhar D, Kestin AS, Bednarek FJ, et al: Neonatal platelets are less reactive than
of neutrophils from stressed neonates. J Pediatr 98:392, 1981. adult platelets to physiological agonists in whole blood. Thromb Haemost 72:957, 1994.
188. Strauss RG, Snyder EL: Neutrophils from human infants exhibit decreased viability. 227. Ts’ao C, Green D, Schultz K: Function and ultrastructure of platelets of neonates;
Pediatr Res 15:794, 1981. enhanced ristocetin aggregation of neonatal platelets. Br J Haematol 32:225, 1976.
189. Strauss RG, Snyder EL, Wallace PO, et al: Oxygen-detoxifying enzymes in neutrophils 228. Blieyer WA, Breckenridge RT: Studies on the detection of adverse drug reactions in the
of infants and their mothers. J Lab Clin Med 95:897, 1980. newborn. II. The effects of prenatal aspirin on newborn hemostasis. JAMA 213:2049,
190. Yamazaki M, Matsuoka T, Yasui K, et al: Increased production of superoxide anion by 1970.
neonatal polymorphonuclear leukocytes stimulated with a chemotactic peptide. Am J 229. Corby DG, Schulman I: The effects of antenatal drug administration on aggregation of
Hematol 27:169, 1988. platelets of newborn infants. J Pediatr 79:307, 1971.
191. Levy O: Impaired innate immunity at birth: Deficiency of bacteriocidal/permeability 230. Hauth JC, Goldenberg RL, Parker CR Jr, et al: Low-dose aspirin: Lack of association
-increasing protein (BPI) in the neutrophils of newborns. Pediatr Res 51:667, 2002. with an increase in abruptio placentae or perinatal mortality. Obstet Gynecol 85:1055,
192. Neupponen I, Turunen R, Nevalainen T, et al: Extracellular release of bactericidal/ 1995.
permeability increasing protein in newborn infants. Pediatr Res 51:670, 2002. 231. Sibai BM, Caritis SN, Thom E, et al: Low-dose aspirin in nulliparous women: Safety
193. Kretschmer RR, Papierniak CK, Stewardson-Krieger P, et al: Quantitative nitroblue of continuous epidural block and correlation between bleeding time and maternal-
tetrazolium reduction by normal newborn monocytes. J Pediatr 91:306, 1977. neonatal bleeding complications. National Institute of Child Health and Human Devel-
194. Milgrom H, Shore SL: Assessment of monocyte function in the normal newborn infant opmental Maternal–Fetal Medicine Network. Am J Obstet Gynecol 172:1553, 1995.
by antibody-dependent cellular cytotoxicity. J Pediatr 91:612, 1977. 232. Newman PJ, Derbes RS, Aster RH: The human platelet alloantigens, PLA1 and PLA2,
195. Orlowski JP, Sieger L, Anthony BF: Bactericidal capacity of monocytes of newborn are associated with a leucine 33/proline 33 amino acid polymorphism in membrane
infants. J Pediatr 89:797, 1976. glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 83:1778, 1989.
196. Schuit KE, Powell DA: Phagocytic dysfunction in monocytes of normal newborn 233. Gruel Y, Boizard B, Daffos F, et al: Determination of platelet antigens and glycoproteins
infants. Pediatrics 65:501, 1980. in the human fetus. Blood 68:488, 1986.
197. Das M, Henderson T, Feig SA: Neonatal mononuclear cell metabolism: Further evi- 234. McFarland JG, Aster RH, Bussel JB, et al: Prenatal diagnosis of neonatal alloim-
dence for diminished monocyte function in the neonate. Pediatr Res 13:632, 1979. mune thrombocytopenia using allele-specific oligonucleotide probes. Blood 78:2276,
198. Mills EL: Mononuclear phagocytes in the newborn: Their relation to the state of relative 1991.
immunodeficiency. Am J Pediatr Hematol Oncol 5:189, 1983.

Kaushansky_chapter 07_p0097-0118.indd 115 9/18/15 10:13 PM